Back to: FDA Compounding Quality Center of Excellence Annual Conference 2025
About:
Learn from a variety of experts about the evolving needs of outsourcing facility customers and the patients they serve. Explore emerging trends, regulatory considerations, and key product demands shaping the future of compounded drugs. Gain valuable perspectives on how outsourcing facilities can better serve a range of healthcare needs in an ever-changing landscape.
Moderators:
Alissa Denker
Regulatory Counsel
FDA
Panel Moderator:
Spencer Malkin
CEO
SKNV
Panelists:
Scott Haber
American Academy of Ophthalmology
Joe Bagan
CEO
STAQ Pharma, Inc.
Jim Lund
Senior Director
Visante Consulting, LLC
Alexander Oshmyansky
CEO
Mark Cuban Cost Plus Drug Company, PBC
Carson Riley
Managing Director, Head of Pharma Investment Banking
Bourne Partners